191 related articles for article (PubMed ID: 31754246)
21. ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.
Cao L; Chen S; Zhang C; Chen C; Lu N; Jiang Y; Cai Y; Yin Y; Xu J
Int J Clin Exp Pathol; 2015; 8(3):2919-27. PubMed ID: 26045800
[TBL] [Abstract][Full Text] [Related]
22. ING4 and ING5 are essential for histone H3 lysine 14 acetylation and epicardial cell lineage development.
Mah SYY; Vanyai HK; Li-Wai-Suen CSN; Garnham AL; Wynn J; Bergamasco MI; Malelang S; Wilcox S; Biben C; Smyth GK; Thomas T; Voss AK
Development; 2024 Mar; 151(5):. PubMed ID: 38446206
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of inhibitor of growth 4 (ING4) dimerization domain reveals functional organization of ING family of chromatin-binding proteins.
Culurgioni S; Muñoz IG; Moreno A; Palacios A; Villate M; Palmero I; Montoya G; Blanco FJ
J Biol Chem; 2012 Mar; 287(14):10876-84. PubMed ID: 22334692
[TBL] [Abstract][Full Text] [Related]
24. Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer.
Shatnawi A; Abu Rabe DI; Frigo DE
Adv Cancer Res; 2021; 152():225-262. PubMed ID: 34353439
[TBL] [Abstract][Full Text] [Related]
25. Two wobble-splicing events affect ING4 protein subnuclear localization and degradation.
Tsai KW; Tseng HC; Lin WC
Exp Cell Res; 2008 Oct; 314(17):3130-41. PubMed ID: 18775696
[TBL] [Abstract][Full Text] [Related]
26. ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth.
Moreno A; Soleto I; García-Sanz P; Moreno-Bueno G; Palmero I
Oncogene; 2014 Apr; 33(15):1945-53. PubMed ID: 23604125
[TBL] [Abstract][Full Text] [Related]
27. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis.
Xie Y; Zhang H; Sheng W; Xiang J; Ye Z; Yang J
Cancer Lett; 2008 Nov; 271(1):105-16. PubMed ID: 18789575
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated ING4/PTEN double tumor suppressor gene co-transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells.
Wang Y; Yang J; Sheng W; Xie Y; Liu J
Int J Oncol; 2015 Mar; 46(3):1295-303. PubMed ID: 25571952
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
Zhao Y; Li Z; Sheng W; Miao J; Yang J
Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
[TBL] [Abstract][Full Text] [Related]
31. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.
Zhang H; Zhou X; Xu C; Yang J; Xiang J; Tao M; Xie Y
Cancer Gene Ther; 2016 Jan; 23(1):13-23. PubMed ID: 26564429
[TBL] [Abstract][Full Text] [Related]
32. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Shatnawi A; Ayoub NM; Alkhalifa AE
Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of ING4 is associated with initiation and progression of lung cancer.
Wang QS; Li M; Zhang LY; Jin Y; Tong DD; Yu Y; Bai J; Huang Q; Liu FL; Liu A; Lee KY; Fu SB
Histopathology; 2010 Aug; 57(2):271-81. PubMed ID: 20716169
[TBL] [Abstract][Full Text] [Related]
34. Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.
Shatnawi A; Malkaram SA; Fandy T; Tsouko E
Mol Cell Biochem; 2020 Jan; 464(1-2):153-167. PubMed ID: 31773467
[TBL] [Abstract][Full Text] [Related]
35. Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma.
Li M; Jin Y; Sun WJ; Yu Y; Bai J; Tong DD; Qi JP; Du JR; Geng JS; Huang Q; Huang XY; Huang Y; Han FF; Meng XN; Rosales JL; Lee KY; Fu SB
J Pathol; 2009 Sep; 219(1):87-95. PubMed ID: 19479822
[TBL] [Abstract][Full Text] [Related]
36. Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.
Mathema VB; Koh YS
Tumour Biol; 2012 Feb; 33(1):1-7. PubMed ID: 21971889
[TBL] [Abstract][Full Text] [Related]
37. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
Shen JC; Unoki M; Ythier D; Duperray A; Varticovski L; Kumamoto K; Pedeux R; Harris CC
Cancer Res; 2007 Mar; 67(6):2552-8. PubMed ID: 17363573
[TBL] [Abstract][Full Text] [Related]
38. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.
Zhu Y; Lv H; Xie Y; Sheng W; Xiang J; Yang J
Cancer Gene Ther; 2011 Sep; 18(9):627-36. PubMed ID: 21660060
[TBL] [Abstract][Full Text] [Related]
39. Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4.
Palacios A; Garcia P; Padró D; López-Hernández E; Martín I; Blanco FJ
FEBS Lett; 2006 Dec; 580(30):6903-8. PubMed ID: 17157298
[TBL] [Abstract][Full Text] [Related]
40. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
